The effects of L-Dopa on attention in Parkinson's disease and Parkinson's dementia patients

被引：0
|
作者：
Molloy, S
McKeith, IG
Burn, D
Wesnes, KA
机构：
[1] Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[2] Cognit Drug Res, Goring On Thames RG8 0EN, England
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2004年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A51 / A51
页数：1
相关论文
共 50 条
  • [1] The effects of L-dopa on attention in Parkinson's disease and Parkinson's dementia patients
    Molloy, S.
    McKeith, I. G.
    Burn, D.
    Wesnes, K. A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 294 - 294
  • [2] Focusing Effects of L-Dopa in Parkinson's Disease
    Ng, Bernard
    Palmer, Samantha
    Abugharbieh, Rafeef
    McKeown, Martin J.
    HUMAN BRAIN MAPPING, 2010, 31 (01) : 88 - 97
  • [3] L-dopa related hyperhomocysteinemia and development of dementia in Parkinson's disease
    dell'Aquila, C.
    Zoccolella, S.
    Mascolo, L.
    Abruzzese, G.
    Antonini, A.
    Bonuccelli, U.
    Dlazio, G.
    Pacchetti, C.
    Lamberti, P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S249 - S249
  • [4] Molecular Effects of L-dopa Therapy in Parkinson's Disease
    Dorszewska, Jolanta
    Prendecki, Michal
    Lianeri, Margarita
    Kozubski, Wojciech
    CURRENT GENOMICS, 2014, 15 (01) : 11 - 17
  • [5] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [6] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [7] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [8] The effect of L-dopa on speech in Parkinson's disease
    Skodda, S.
    Schlegel, U.
    JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (02) : 233 - 233
  • [9] Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa
    A. W. Michell
    Z. Xu
    D. Fritz
    S. J. G. Lewis
    T. Foltynie
    C. H. Williams-Gray
    T. W. Robbins
    R. H. S. Carpenter
    R. A. Barker
    Experimental Brain Research, 2006, 174 : 7 - 18
  • [10] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    AMINO ACIDS, 2005, 28 (02) : 157 - 164
12345